Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dQvbCduTtWCelQuHCidmzaCicNbnIH
| FDA Oks Prostate Cancer Drug 3 Months Ahead of PDUFA Date | | San Francisco-based Medivation Inc. and Astellas Pharma Inc. had plenty to celebrate heading into the Labor Day weekend. The FDA on Friday approved Xtandi (enzalutamide) capsules for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC). Find out the details. |  |
| Health Care & Policy |  |  | | - AMAG obtains Swiss approval for anemia drug
The Swiss Agency for Therapeutic Products granted AMAG Pharmaceuticals approval to market its iron deficiency anemia drug in adult patients with chronic kidney disease. AMAG's partner Takeda Pharmaceutical will sell the drug in Switzerland under the brand name Rienso. The drug, also known as Feraheme, is already cleared in the U.S., Canada and the European Union. Mass High Tech (Boston) (9/5)       - FDA OKs 2 herpes virus assays from Roche Diagnostics
The FDA has given Roche Diagnostics the go-ahead to sell two automated assays for the IgG Antibody, which is used to spot herpes simplex virus types 1 and 2. The tests will run on the company's cobas modular analytical platforms and is designed for use in detecting virus infections on expectant mothers and in sexually active individuals. MedCityNews.com (9/4) - Atox eyes more money to develop drug for severe infections
Atox Bio aims to raise more funds from investors this year to develop an experimental treatment for severe infections such as those caused by deadly viruses and flesh-eating bacteria. The drugmaker plans to start an expanded Phase IIb study next year to examine the drug's long-term effects. Atox already raised $7 million from Esperante Ventures and another private investor and was granted more than $12 million by the government. Reuters (9/4)  |  |  | | How to turn money you already spend into points you can use:
The Business Gold Rewards Card from American Express OPEN, designed to earn Membership Rewards® points faster: 3X on airfare, 2X on advertising, gas & shipping. 1X on everything else. Use points to pay for travel, Amazon.com purchases, Facebook ads, and more. Limited Time Offer: 50K bonus points when you spend $5K in your first 3 months of Card membership†
LEARN MORE & APPLY †Terms & Restrictions Apply. | |  |  |  |
  | Company & Financial News | | | | | Industry Deals | | | |
| Food & Agriculture | | | | | Industrial & Environmental | | | | | News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here.
| SmartQuote | | | |  | One never notices what has been done; one can only see what remains to be done."
--Marie Curie,
Polish-French physicist and chemist  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, September 05, 2012
- Tuesday, September 04, 2012
- Friday, August 31, 2012
- Thursday, August 30, 2012
- Wednesday, August 29, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment